United States
Germany
Japan
United Kingdom
China
UNG mouse monoclonal antibody, clone OTI2C12 (formerly 2C12)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Antibodies
APEX1 mouse monoclonal antibody, clone OTI6E10 (formerly 6E10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) APEX1 mouse monoclonal antibody, clone OTI6E10 (formerly 6E10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
APEX1 mouse monoclonal antibody, clone OTI2A4 (formerly 2A4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
APEX1 mouse monoclonal antibody,clone 6E10, Biotinylated
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
APEX1 mouse monoclonal antibody,clone 6E10, HRP conjugated
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
APEX1 mouse monoclonal antibody,clone 2A4, Biotinylated
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
CNY 3,990.00
2周
APEX1 mouse monoclonal antibody,clone 2A4, HRP conjugated
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
Carrier-free (BSA/glycerol-free) APEX1 mouse monoclonal antibody, clone OTI2A4 (formerly 2A4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
VASP mouse monoclonal antibody, clone OTI4D6 (formerly 4D6)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Rat, Mouse |
APEX1 mouse monoclonal antibody, clone OTI6E10 (formerly 6E10)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
APEX1 mouse monoclonal antibody, clone OTI2A4 (formerly 2A4)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
VASP mouse monoclonal antibody, clone OTI1H8 (formerly 1H8)
| Applications | FC, IF, WB |
| Reactivities | Human, Mouse, Rat |
CHEK2 (CHK2) mouse monoclonal antibody, clone OTI5C4 (formerly 5C4)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Dog, Mouse, Rat |
